Immune suppression in the early stage of COVID-19 disease
How COVID-19 pathology differs from other drivers of pneumonia is unclear. Here the authors analyze urine from patients with COVID-19 and identify an immunosuppressive protein expression pattern that is distinct from the pattern in healthy individuals or patients with non-COVID-19 pneumonia.
Guardado en:
Autores principales: | Wenmin Tian, Nan Zhang, Ronghua Jin, Yingmei Feng, Siyuan Wang, Shuaixin Gao, Ruqin Gao, Guizhen Wu, Di Tian, Wenjie Tan, Yang Chen, George Fu Gao, Catherine C. L. Wong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/788f9dfbff9d42378d21e26566e71d04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage
por: Juan Liu, et al.
Publicado: (2017) -
THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
por: V. A. Lyashenko, et al.
Publicado: (2014) -
The homeobox protein VentX reverts immune suppression in the tumor microenvironment
por: Yi Le, et al.
Publicado: (2018) -
Early Immune Response Elicited by Different Trypanosoma cruzi Infective Stages
por: Brenda Celeste Gutierrez, et al.
Publicado: (2021) -
Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China
por: Yongzhi Li, et al.
Publicado: (2021)